Related references
Note: Only part of the references are listed.The size of solid lipid nanoparticles: An interpretation from experimental design
Carla Vitorino et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2011)
Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: Influences of fatty acids
Shuyu Xie et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2011)
In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain
Lucia Montenegro et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2011)
Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting
M. R. Aji Alex et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration
Cheng-Feng Luo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Preparation and Enhanced Oral Bioavailability of Cryptotanshinone-Loaded Solid Lipid Nanoparticles
LianDong Hu et al.
AAPS PHARMSCITECH (2010)
Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug
Ashay Jain et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles
Shuyu Xie et al.
NANOMEDICINE (2010)
Lipid Nanomedicines for Anticancer Drug Therapy
Ander Estella-Hermoso de Mendoza et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2009)
Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles
HouLi Li et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement
Baboota Sanjula et al.
JOURNAL OF DRUG TARGETING (2009)
Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery
Rishi Paliwal et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2009)
Lipid Nanoparticles with a Solid Matrix (SLN, NLC, LDC) for Oral Drug Delivery
Marc Muchow et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2008)
Cyclosporine-loaded solid lipid nanoparticles (SLN®):: Drug-lipid physicochemical interactions and characterization of drug incorporation
R. H. Mueller et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Solid lipid nanoparticles as delivery systems for bioactive food components
Jochen Weiss et al.
FOOD BIOPHYSICS (2008)
Design and production of nanoparticles formulated from nano-emulsion templates - A review
Nicolas Anton et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Temperature Scanning Ultrasonic Velocity Study of Complex Thermal Transformations in Solid Lipid Nanoparticles
Tarek Samir Awad et al.
LANGMUIR (2008)
Studies on oral absorption of stearic acid SLN by a novel fluorometric method
Hong Yuan et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2007)
Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug
A. Hanafy et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Stability of lipid exciplents in solid lipid nanoparticles
Anna Radornska-Soukharev
ADVANCED DRUG DELIVERY REVIEWS (2007)
Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles
K. Vivek et al.
AAPS PHARMSCITECH (2007)
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin
Na Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
Anne des Rieux et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration
Kopparam Manjunath et al.
JOURNAL OF DRUG TARGETING (2006)
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability
YiFan Luo et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Oral bioavailability of cyclosporine:: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
R. H. Mueller et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Influence of the formulation for solid lipid nanoparticles prepared with a membrane contactor
Assma Ahmed El-Harati et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2006)
Preparation of solid lipid nanoparticles using a membrane contactor
C Charcosset et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration
K Manjunath et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting
TM Göppert et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Oral solid lipid nanoparticle-based antitubercular chemotherapy
R Pandey et al.
TUBERCULOSIS (2005)
Characterisation of surface-modified solid lipid nanoparticles (SLN):: Influence of lecithin and nonionic emulsifier
MA Schubert et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2005)
The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle
ZN Mei et al.
PHARMACOLOGICAL RESEARCH (2005)
Solid lipid nanoparticles as drug delivery systems
K Manjunath et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2005)
Solid lipid namoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs
LD Hu et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2004)
Solid lipid nanoparticles for parenteral drug delivery
SA Wissing et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin
R Cavalli et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Cosmetic applications for solid lipid nanoparticles (SLN)
SA Wissing et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats
GP Zara et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel
DB Chen et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2001)
Solid lipid nanoparticles -: Production, characterization and applications
W Mehnert et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Solid lipid nanoparticles (SLN) for controlled drug delivery -: a review of the state of the art
RH Müller et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
Comparison of wax and glyceride solid lipid nanoparticles (SLN®)
V Jenning et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Share Paper
